|
1
|
Hansson EM, Lendahl U and Chapman G: Notch
signaling in development and disease. Semin Cancer Biol.
14:320–328. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zanotti S and Canalis E: Notch and the
skeleton. Mol Cell Biol. 30:886–896. 2010. View Article : Google Scholar :
|
|
3
|
Campbell DP, Chrysostomou E and
Doetzlhofer A: Canonical Notch signaling plays an instructive role
in auditory supporting cell development. Sci Rep. 6:194842016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kopan R and Ilagan MX: The canonical Notch
signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colombo M, Galletti S, Garavelli S,
Platonova N, Paoli A, Basile A, Taiana E, Neri A and Chiaramonte R:
Notch signaling deregulation in multiple myeloma: A rational
molecular target. Oncotarget. 6:26826–26840. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li
H and Du J: The Notch γ-secretase inhibitor ameliorates kidney
fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway
activation. Int J Biochem Cell Biol. 55:65–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Artavanis-Tsakonas S, Matsuno K and
Fortini ME: Notch signaling. Science. 268:225–232. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ehebauer M, Hayward P and Arias AM: Notch,
a universal arbiter of cell fate decisions. Science. 314:1414–1415.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bi P and Kuang S: Notch signaling as a
novel regulator of metabolism. Trends Endocrinol Metab. 26:248–255.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colombo M, Thümmler K, Mirandola L,
Garavelli S, Todoerti K, Apicella L, Lazzari E, Lancellotti M,
Platonova N, Akbar M, et al: Notch signaling drives multiple
myeloma induced osteoclastogenesis. Oncotarget. 5:10393–10406.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kushwah R, Guezguez B, Lee JB, Hopkins CI
and Bhatia M: Pleiotropic roles of Notch signaling in normal,
malignant, and developmental hematopoiesis in the human. EMBO Rep.
15:1128–1138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wahi K, Bochter MS and Cole SE: The many
roles of Notch signaling during vertebrate somitogenesis. Semin
Cell Dev Biol. 49:68–75. 2016. View Article : Google Scholar
|
|
13
|
Tao J, Chen S, Yang T, Dawson B, Munivez
E, Bertin T and Lee B: Osteosclerosis owing to Notch gain of
function is solely Rbpj-dependent. J Bone Miner Res. 25:2175–2183.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong Y, Jesse AM, Kohn A, Gunnell LM,
Honjo T, Zuscik MJ, O'Keefe RJ and Hilton MJ: RBPjkappa-dependent
Notch signaling regulates mesenchymal progenitor cell proliferation
and differentiation during skeletal development. Development.
137:1461–1471. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong Y, Long T, Wang C, Mirando AJ, Chen
J, O'Keefe RJ and Hilton MJ: NOTCH-mediated maintenance and
expansion of human bone marrow stromal/stem cells: A technology
designed for orthopedic regenerative medicine. Stem Cells Transl
Med. 3:1456–1466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sánchez-Duffhues G, Hiepen C, Knaus P and
Ten Dijke P: Bone morphogenetic protein signaling in bone
homeostasis. Bone. 80:43–59. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katagiri T and Watabe T: Bone
morphogenetic proteins. Cold Spring Harb Perspect Biol. 8:82016.
View Article : Google Scholar
|
|
18
|
Miyazono K, Maeda S and Imamura T: BMP
receptor signaling: Transcriptional targets, regulation of signals,
and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brazil DP, Church RH, Surae S, Godson C
and Martin F: BMP signalling: Agony and antagony in the family.
Trends Cell Biol. 25:249–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sieber C, Kopf J, Hiepen C and Knaus P:
Recent advances in BMP receptor signaling. Cytokine Growth Factor
Rev. 20:343–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hogan BL: Bone morphogenetic proteins:
Multifunctional regulators of vertebrate development. Genes Dev.
10:1580–1594. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen G, Deng C and Li YP: TGF-β and BMP
signaling in osteoblast differentiation and bone formation. Int J
Biol Sci. 8:272–288. 2012. View Article : Google Scholar :
|
|
23
|
Peng Y, Kang Q, Cheng H, Li X, Sun MH,
Jiang W, Luu HH, Park JY, Haydon RC and He TC: Transcriptional
characterization of bone morphogenetic proteins (BMPs)-mediated
osteogenic signaling. J Cell Biochem. 90:1149–1165. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmidt-Bleek K, Willie BM, Schwabe P,
Seemann P and Duda GN: BMPs in bone regeneration: Less is more
effective, a paradigm-shift. Cytokine Growth Factor Rev.
27:141–148. 2016. View Article : Google Scholar
|
|
25
|
Beederman M, Lamplot JD, Nan G, Wang J,
Liu X, Yin L, Li R, Shui W, Zhang H, Kim SH, et al: BMP signaling
in mesenchymal stem cell differentiation and bone formation. J
Biomed Sci Eng. 6:32–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Poon B, Kha T, Tran S and Dass CR: Bone
morphogenetic protein-2 and bone therapy: Successes and pitfalls. J
Pharm Pharmacol. 68:139–147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang Q, Sun MH, Cheng H, Peng Y, Montag
AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, et al:
Characterization of the distinct orthotopic bone-forming activity
of 14 BMPs using recombinant adenovirus-mediated gene delivery.
Gene Ther. 11:1312–1320. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luu HH, Song WX, Luo X, Manning D, Luo J,
Deng ZL, Sharff KA, Montag AG, Haydon RC and He TC: Distinct roles
of bone morphogenetic proteins in osteogenic differentiation of
mesenchymal stem cells. J Orthop Res. 25:665–677. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng H, Jiang W, Phillips FM, Haydon RC,
Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, et al:
Osteogenic activity of the fourteen types of human bone
morphogenetic proteins (BMPs). J Bone Joint Surg Am.
85-A:1544–1552. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bi J and Ge S: Potential roles of BMP9 in
liver fibrosis. Int J Mol Sci. 15:20656–20667. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mi LZ, Brown CT, Gao Y, Tian Y, Le VQ,
Walz T and Springer TA: Structure of bone morphogenetic protein 9
procomplex. Proc Natl Acad Sci USA. 112:3710–3715. 2015.PubMed/NCBI
|
|
32
|
Hu N, Jiang D, Huang E, Liu X, Li R, Liang
X, Kim SH, Chen X, Gao JL, Zhang H, et al: BMP9-regulated
angiogenic signaling plays an important role in the osteogenic
differentiation of mesenchymal progenitor cells. J Cell Sci.
126:532–541. 2013. View Article : Google Scholar :
|
|
33
|
Song JJ, Celeste AJ, Kong FM, Jirtle RL,
Rosen V and Thies RS: Bone morphogenetic protein-9 binds to liver
cells and stimulates proliferation. Endocrinology. 136:4293–4297.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dahlqvist C, Blokzijl A, Chapman G, Falk
A, Dannaeus K, Ibâñez CF and Lendahl U: Functional Notch signaling
is required for BMP4-induced inhibition of myogenic
differentiation. Development. 130:6089–6099. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Viale-Bouroncle S, Gosau M and Morsczeck
C: NOTCH1 signaling regulates the BMP2/DLX-3 directed osteogenic
differentiation of dental follicle cells. Biochem Biophys Res
Commun. 443:500–504. 2014. View Article : Google Scholar
|
|
36
|
Shin M, Nagai H and Sheng G: Notch
mediates Wnt and BMP signals in the early separation of smooth
muscle progenitors and blood/endothelial common progenitors.
Development. 136:595–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo X and Wang XF: Signaling cross-talk
between TGF-β/BMP and other pathways. Cell Res. 19:71–88. 2009.
View Article : Google Scholar
|
|
38
|
Sartori R, Gregorevic P and Sandri M:
TGFbeta and BMP signaling in skeletal muscle: Potential
significance for muscle-related disease. Trends Endocrinol Metab.
25:464–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang JH, Liu YZ, Yin LJ, Chen L, Huang J,
Liu Y, Zhang RX, Zhou LY, Yang QJ, Luo JY, et al: BMP9 and COX-2
form an important regulatory loop in BMP9-induced osteogenic
differentiation of mesenchymal stem cells. Bone. 57:311–321. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li L, Dong Q, Wang Y, Feng Q, Zhou P, Ou
X, Meng Q, He T and Luo J: Hedgehog signaling is involved in the
BMP9-induced osteogenic differentiation of mesenchymal stem cells.
Int J Mol Med. 35:1641–1650. 2015.PubMed/NCBI
|
|
41
|
Song T, Wang W, Xu J, Zhao D, Dong Q, Li
L, Yang X, Duan X, Liang Y, Xiao Y, et al: Fibroblast growth factor
2 inhibits bone morphogenetic protein 9-induced osteogenic
differentiation of mesenchymal stem cells by repressing Smads
signaling and subsequently reducing Smads dependent up-regulation
of ALK1 and ALK2. Int J Biochem Cell Biol. 45:1639–1646. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Luo J, Tang M, Huang J, He BC, Gao JL,
Chen L, Zuo GW, Zhang W, Luo Q, Shi Q, et al: TGFbeta/BMP type I
receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic
signaling in mesenchymal stem cells. J Biol Chem. 285:29588–29598.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao Y, Song T, Wang W, Wang J, He J, Wu
N, Tang M, He B and Luo J: P38 and ERK1/2 MAPKs act in opposition
to regulate BMP9-induced osteogenic differentiation of mesenchymal
progenitor cells. PLoS One. 7:e433832012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang J, Weng Y, Liu X, Wang J, Zhang W,
Kim SH, Zhang H, Li R, Kong Y, Chen X, et al: Endoplasmic reticulum
(ER) stress inducible factor cysteine-rich with EGF-like domains 2
(Creld2) is an important mediator of BMP9-regulated osteogenic
differentiation of mesenchymal stem cells. PLoS One. 8:e730862013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Luther G, Wagner ER, Zhu G, Kang Q, Luo Q,
Lamplot J, Bi Y, Luo X, Luo J, Teven C, et al: BMP-9 induced
osteogenic differentiation of mesenchymal stem cells: Molecular
mechanism and therapeutic potential. Curr Gene Ther. 11:229–240.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang H, Wang J, Deng F, Huang E, Yan Z,
Wang Z, Deng Y, Zhang Q, Zhang Z, Ye J, et al: Canonical Wnt
signaling acts synergistically on BMP9-induced osteo/odontoblastic
differentiation of stem cells of dental apical papilla (SCAPs).
Biomaterials. 39:145–154. 2015. View Article : Google Scholar
|
|
47
|
Shimizu T, Tanaka T, Iso T, Matsui H,
Ooyama Y, Kawai-Kowase K, Arai M and Kurabayashi M: Notch signaling
pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness
of Msx2 gene to induce osteogenic differentiation and
mineralization of vascular smooth muscle cells. J Biol Chem.
286:19138–19148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
de Jong DS, Steegenga WT, Hendriks JM, van
Zoelen EJ, Olijve W and Dechering KJ: Regulation of Notch signaling
genes during BMP2-induced differentiation of osteoblast precursor
cells. Biochem Biophys Res Commun. 320:100–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nobta M, Tsukazaki T, Shibata Y, Xin C,
Moriishi T, Sakano S, Shindo H and Yamaguchi A: Critical regulation
of bone morphogenetic protein-induced osteoblastic differentiation
by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem.
280:15842–15848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shimizu T, Tanaka T, Iso T, Doi H, Sato H,
Kawai-Kowase K, Arai M and Kurabayashi M: Notch signaling induces
osteogenic differentiation and mineralization of vascular smooth
muscle cells: Role of Msx2 gene induction via Notch-RBP-Jk
signaling. Arterioscler Thromb Vasc Biol. 29:1104–1111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hilton MJ, Tu X, Wu X, Bai S, Zhao H,
Kobayashi T, Kronenberg HM, Teitelbaum SL, Ross FP, Kopan R, et al:
Notch signaling maintains bone marrow mesenchymal progenitors by
suppressing osteoblast differentiation. Nat Med. 14:306–314. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Miyazono K, Kamiya Y and Morikawa M: Bone
morphogenetic protein receptors and signal transduction. J Biochem.
147:35–51. 2010. View Article : Google Scholar
|
|
53
|
Culbert AL, Chakkalakal SA, Theosmy EG,
Brennan TA, Kaplan FS and Shore EM: Alk2 regulates early
chondrogenic fate in fibrodysplasia ossificans progressiva
heterotopic endo-chondral ossification. Stem Cells. 32:1289–1300.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang D, Schwarz EM, Rosier RN, Zuscik MJ,
Puzas JE and O'Keefe RJ: ALK2 functions as a BMP type I receptor
and induces Indian hedgehog in chondrocytes during skeletal
development. J Bone Miner Res. 18:1593–1604. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Katagiri T: A door opens for
fibrodysplasia ossificans progressiva. Trends Biochem Sci.
41:119–121. 2016. View Article : Google Scholar
|
